Why Lifting Weights Twice a Week Lowers All-Cause Mortality by 16 Percent

The Workout That Outperforms Most Pharmaceuticals: Two strength-training sessions per week — totalling roughly 90 minutes of moderate effort — produce an all-cause mortality reduction comparable to the effect of many widely-prescribed cardiovascular medications. The effect operates independently of aerobic exercise, persists across age groups, and is now documented across multiple meta-analyses representing more than a million participants. The intervention is cheap, safe, broadly accessible — and remains substantially underused by the adults whose long-term health depends most on it.

The clinical case for resistance training has matured rapidly in the past decade. A landmark 2022 meta-analysis published in the British Journal of Sports Medicine by Haruki Momma and colleagues at Tohoku University pooled 16 prospective cohort studies covering more than 1.1 million participants. The conclusion: adults engaging in muscle-strengthening activities at least twice weekly showed a 16 percent reduction in all-cause mortality, with parallel reductions in cardiovascular disease and several cancers, after controlling for aerobic exercise levels and other lifestyle factors [cite: Momma et al., Br J Sports Med, 2022].

The 16 percent figure is large. For comparison, the all-cause mortality reduction from standard statin therapy in primary-prevention populations is generally in the 10–15 percent range. The mortality reduction from quitting smoking after 15 years is substantial but not unreachable by exercise. The implication is significant: a behavioural intervention has produced an effect size that, in pharmaceutical terms, would be considered a blockbuster outcome.

1. Why Resistance Training Is Mechanistically Distinct From Cardio

The biological pathways through which resistance training produces its mortality benefits are partly overlapping with and partly distinct from aerobic exercise:

• Skeletal Muscle Mass Preservation: Sarcopenia — age-related muscle loss — is one of the strongest predictors of late-life disability and mortality. Resistance training is the only intervention that reliably prevents it.
• Glucose Disposal: Skeletal muscle is the body’s largest glucose reservoir. More muscle mass produces measurable improvements in insulin sensitivity that aerobic exercise alone cannot match.
• Bone Density: Resistance training is the most effective non-pharmaceutical intervention for preserving bone density, with downstream effects on hip-fracture mortality that are particularly significant in older adults.
• Metabolic Rate Maintenance: Muscle is metabolically expensive; more muscle keeps basal metabolic rate elevated, supporting weight regulation and metabolic flexibility.

2. The Dose-Response Curve

One of the most useful findings of the resistance-training literature is the shape of the dose-response curve. The largest mortality reductions appear at relatively modest training volumes:

• Zero Sessions Per Week: Baseline elevated mortality.
• One Session Per Week: Small but detectable reduction.
• Two Sessions Per Week: Optimal in most cohort studies; 16 percent reduction documented.
• Three to Four Sessions Per Week: Comparable to two sessions; little additional mortality benefit.
• More Than Five Sessions Per Week: Effect may plateau or, in some studies, slightly reverse — possibly due to overtraining or injury risk.

The curve is unusually accessible. The full mortality benefit appears at approximately 60–90 minutes per week of total training — well within the practical reach of nearly every working adult.

3. Why Older Adults Need It Most

The mortality-reduction effect of resistance training is particularly pronounced in older adults — the population for whom the underlying mechanisms (sarcopenia prevention, bone density, glucose handling) matter most. Adults over 60 who incorporate resistance training show measurably better outcomes on disability prevention, fall reduction, and independent-living preservation than peers who confine their exercise to walking and aerobic activities alone.

The cultural framing of resistance training as a young adult’s activity — gym culture’s emphasis on physique and athletic performance — has been a public-health barrier. The clinical evidence supports the opposite framing: the older the adult, the larger the marginal benefit per session of resistance training, and the more important the intervention becomes.

4. How to Build a Sustainable Resistance Training Practice

The protocols below convert the mortality-reduction research into actionable practice for adults at any starting point.

• Two Sessions Per Week, 45 Minutes Each: The minimum effective dose for capturing most of the documented mortality benefit. Anything beyond is bonus.
• Focus on Compound Movements: Squats, deadlifts, presses, rows, and pull-ups cover most major muscle groups efficiently. Isolation exercises produce smaller per-minute returns.
• Train to Genuine Effort: The mortality-reduction studies typically involved meaningful resistance, not light-load high-rep work. The cellular adaptations require sufficient load.
• Bodyweight Is Sufficient for Beginners: Push-ups, squats, lunges, and rows performed from a bar produce substantial benefit before any gym equipment is required.
• Maintain Across Decades: The mortality benefits accumulate. The professional in their 50s who has been training consistently for 20 years has a substantially better outcome trajectory than the same person starting at 60.

Conclusion: The Cheapest Mortality-Reduction Intervention Is the One Most Adults Treat as Optional

The case for resistance training has matured from a fitness-culture preference to a mainstream preventive-medicine prescription. The effect sizes documented across multiple large meta-analyses are competitive with the most-prescribed pharmaceutical interventions, and the intervention itself costs little, produces no side-effect profile to manage, and remains feasible into late life. The reader who treats two weekly sessions as optional is, on the data, declining a 16 percent mortality reduction that the underlying biology has been quietly offering.

Are you investing 90 minutes a week in the intervention that, on the data, outperforms most pharmaceuticals on the outcome that matters most — or are you skipping it on the grounds that the gym does not feel like medicine?